Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Memory and Emotion in Treatment-Resistant Depression
NCT05809609Recruiting
- Sponsor
- University of Oxford
- Start
- Jul 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in treatment-resistant depression (TRD) comparing Ketamine with Placebo (2 arms). Primary endpoints: Change in magnitude of negative and positive valence adjectives in the autobiographical memory task at 1 day and Brain activation as measured by functional magnetic resonance in a network of areas related to autobiographical memories at 1 day. Started Jul 2022; status: recruiting.
02
Drugs
ketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT05809609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05809609.